MEDIFAST INC (MED) Stock Price, Quote, News and Overview
NYSE:MED - New York Stock Exchange, Inc. - US58470H1014 - Common Stock - Currency: USD
MED Quote, Performance and Key Statistics
13.59
+0.33 (+2.49%)
The current stock price of MED is 13.59 USD. In the past month the price increased by 3.58%. In the past year, price decreased by -31.05%.
MED Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 23.64 | 154.78B | ||
| KVUE | KENVUE INC | 19.56 | 41.32B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 34.37 | 25.35B | ||
| BRBR | BELLRING BRANDS INC | 28.39 | 7.79B | ||
| ELF | ELF BEAUTY INC | 34.8 | 6.65B | ||
| COTY | COTY INC-CL A | 21.42 | 4.48B | ||
| IPAR | INTERPARFUMS INC | 26.47 | 4.48B | ||
| ODD | ODDITY TECH LTD-CL A | 35.07 | 3.97B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 9.08 | 1.23B | ||
| OLPX | OLAPLEX HOLDINGS INC | 16.63 | 885.67M | ||
| HLF | HERBALIFE LTD | 4.01 | 842.30M | ||
| YSG | YATSEN HOLDING LTD-ADR | N/A | 807.19M |
Related stock screener links
About MED
Company Profile
Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. The company is headquartered in Baltimore, Maryland and currently employs 504 full-time employees. The firm is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. The company sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Company Info
MEDIFAST INC
100 International Drive, 18th Floor
Baltimore MARYLAND 21202 US
CEO: Daniel R. Chard
Employees: 504
Phone: 14105818042
MEDIFAST INC / MED FAQ
What is the stock price of MEDIFAST INC today?
The current stock price of MED is 13.59 USD. The price increased by 2.49% in the last trading session.
What is the ticker symbol for MEDIFAST INC stock?
The exchange symbol of MEDIFAST INC is MED and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is MED stock listed?
MED stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for MEDIFAST INC stock?
8 analysts have analysed MED and the average price target is 15.3 USD. This implies a price increase of 12.58% is expected in the next year compared to the current price of 13.59. Check the MEDIFAST INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MEDIFAST INC worth?
MEDIFAST INC (MED) has a market capitalization of 149.35M USD. This makes MED a Micro Cap stock.
How many employees does MEDIFAST INC have?
MEDIFAST INC (MED) currently has 504 employees.
What are the support and resistance levels for MEDIFAST INC (MED) stock?
MEDIFAST INC (MED) has a support level at 12.52 and a resistance level at 13.6. Check the full technical report for a detailed analysis of MED support and resistance levels.
Is MEDIFAST INC (MED) expected to grow?
The Revenue of MEDIFAST INC (MED) is expected to decline by -34.73% in the next year. Check the estimates tab for more information on the MED EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MEDIFAST INC (MED) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MED, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MED, evaluating the profitability, health, valuation and growth aspects
- MEDIFAST INC (MED) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDIFAST INC (MED) Sales and EPS estimates to see what analysts future expectations are.
- MEDIFAST INC (MED) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDIFAST INC (MED) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDIFAST INC (MED) Stock Chart to make your own analysis
- MEDIFAST INC (MED) Latest news and press-releases to stay up to date.
Does MEDIFAST INC (MED) stock pay dividends?
MEDIFAST INC (MED) has a dividend yield of 9.97%. The yearly dividend amount is currently 0.07. Check the full fundamental report for a detailed analysis of MED dividend history, reliability and sustainability.
When does MEDIFAST INC (MED) report earnings?
MEDIFAST INC (MED) will report earnings on 2025-08-04, after the market close.
What is the Price/Earnings (PE) ratio of MEDIFAST INC (MED)?
The PE ratio for MEDIFAST INC (MED) is 10.87. This is based on the reported non-GAAP earnings per share of 1.25 and the current share price of 13.59 USD. Check the full fundamental report for a full analysis of the valuation metrics for MED.
What is the Short Interest ratio of MEDIFAST INC (MED) stock?
The outstanding short interest for MEDIFAST INC (MED) is 13.11% of its float. Check the ownership tab for more information on the MED short interest.
MED Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to MED. When comparing the yearly performance of all stocks, MED is a bad performer in the overall market: 84.9% of all stocks are doing better.
MED Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to MED. MED is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
MED Financial Highlights
Over the last trailing twelve months MED reported a non-GAAP Earnings per Share(EPS) of 1.25. The EPS decreased by -79.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.5% | ||
| ROE | -3.32% | ||
| Debt/Equity | 0 |
MED Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 45% to MED. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -149.75% and a revenue growth -34.73% for MED